Praxis Precision Medicines (PRAX) Non Operating Income (2019 - 2026)

Praxis Precision Medicines' Non Operating Income history runs 8 years deep, the most recent figure standing at $13.3 million for Q1 2026.

• On a quarterly basis, Non Operating Income rose 144.83% year-over-year to $13.3 million in Q1 2026; TTM through Mar 2026 was $30.8 million, a 50.63% increase from a year earlier, with the FY2025 full-year figure at $22.9 million, up 32.19% from the prior year.
• Non Operating Income climbed to $13.3 million in Q1 2026 per PRAX's latest filing, from $8.1 million in the prior quarter.
• Across five years, Non Operating Income topped out at $13.3 million in Q1 2026 and bottomed at $132000.0 in Q1 2022.
• The 5-year median for Non Operating Income is $2.3 million (2024), against an average of $3.4 million.
• Across the five-year window, Non Operating Income jumped 642.44% in 2024 and retreated 10.15% in 2025, its largest moves.
• Year by year, Non Operating Income stood at $280000.0 in 2022, then soared by 231.43% to $928000.0 in 2023, then surged by 468.64% to $5.3 million in 2024, then surged by 54.12% to $8.1 million in 2025, then jumped by 63.52% to $13.3 million in 2026.
• Per Business Quant, the three latest PRAX Non Operating Income figures stand at $13.3 million (Q1 2026), $8.1 million (Q4 2025), and $4.4 million (Q3 2025).